← Open Payments lookup

KATHLEEN LALLY: Open Payments

NPI 1508365842 · NORMAL, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,721 in 122 payments from 27 companies in 2025. Trend: 2023 $2,407 · 2024 $2,582 · 2025 $3,721

Food & beverage: $2,740Travel & lodging: $846Education: $134
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation14$1,278
CSL Behring20$308
Takeda Pharmaceuticals U.S.A., Inc.12$295
GENZYME CORPORATION12$269
AstraZeneca Pharmaceuticals LP10$263
ARS Pharmaceuticals Operations, Inc.9$141
Genentech USA, Inc.5$127
Incyte Corporation1$100
SANOFI-AVENTIS U.S. LLC1$100
GlaxoSmithKline, LLC.5$97

Products named: DUPIXENT, AIRSUPRA, Xolair, NEFFY, CUVITRU, Hizentra, Andembry, AYVAKIT.

Industry payments across IL — which companies pay providers there.